Discontinuation report UNIPHYL
| Report ID | 133063 |
| Drug Identification Number | 02014165 |
| Brand name | UNIPHYL |
| Common or Proper name | Uniphyl |
| Company Name | ELVIUM LIFE SCIENCES |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | THEOPHYLLINE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 50 |
| ATC code | R03DA |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-02-08 |
| Actual discontinuation date | |
| Remaining supply date | 2021-02-08 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2021-02-01 | French | Compare |
| v1 | 2021-02-01 | English | Compare |
Showing 1 to 2 of 2